We are live on ! Find out more
XS

XR Securities Portfolio holdings

AUM $5.35M
1-Year Est. Return 26.1%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+26.1%
3 Year Est. Return
+16.97%
5 Year Est. Return
+76.98%
10 Year Est. Return
AUM
$3.83B
AUM Growth
+$2.8B
Cap. Flow
+$2.58B
Cap. Flow %
67.36%
Top 10 Hldgs %
82.2%
Holding
598
New
97
Increased
148
Reduced
161
Closed
190

Sector Composition

Rank Sector Weight
1 Healthcare 0.25%
2 Consumer Discretionary 0.22%
3 Technology 0.2%
4 Industrials 0.17%
5 Financials 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
226
CALL
Union Pacific
UNP
$174B
$684K 0.02%
3,400
-17,300
-84% -$3.51M
LOW icon
227
CALL
Lowe's Companies
LOW
$121B
$680K 0.02%
3,400
-4,600
-58% -$934K
BAC icon
228
PUT
Bank of America
BAC
$429B
$672K 0.02%
+23,500
New +$776K
MRNA icon
229
PUT
Moderna
MRNA
$21.6B
$660K 0.02%
4,300
-10,300
-71% -$1.7M
ARKK icon
230
CALL
ARK Innovation ETF
ARKK
$5.59B
$654K 0.02%
16,200
+5,300
+49% +$203K
DE icon
231
Deere & Co
DE
$165B
$649K 0.02%
1,573
+233
+17% +$96.5K
TTD icon
232
PUT
Trade Desk
TTD
$8.97B
$627K 0.02%
10,300
+3,000
+41% +$160K
JNJ icon
233
Johnson & Johnson
JNJ
$640B
$619K 0.02%
+3,991
New +$644K
TLT icon
234
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
$606K 0.02%
5,700
-6,300
-53% -$659K
NOW icon
235
CALL
ServiceNow
NOW
$120B
$604K 0.02%
6,500
-67,500
-91% -$5.88M
BX icon
236
Blackstone
BX
$104B
$603K 0.02%
6,869
+1,033
+18% +$91.2K
PRVB
237
CALL
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$603K 0.02%
+25,000
New +$314K
MS icon
238
CALL
Morgan Stanley
MS
$319B
$597K 0.02%
6,800
+800
+13% +$74.7K
PM icon
239
PUT
Philip Morris
PM
$309B
$593K 0.02%
6,100
-5,100
-46% -$508K
FCX icon
240
CALL
Freeport-McMoran
FCX
$86.2B
$589K 0.02%
14,400
+3,000
+26% +$125K
RH icon
241
PUT
RH
RH
$3.33B
$585K 0.02%
+2,400
New +$697K
AMAT icon
242
CALL
Applied Materials
AMAT
$347B
$577K 0.02%
4,700
-2,100
-31% -$241K
ALB icon
243
PUT
Albemarle
ALB
$13.4B
$575K 0.02%
2,600
-1,100
-30% -$271K
XBI icon
244
CALL
State Street SPDR S&P Biotech ETF
XBI
$10B
$572K 0.01%
+7,500
New +$622K
SLB icon
245
PUT
SLB Ltd
SLB
$72.7B
$570K 0.01%
11,600
-2,000
-15% -$106K
SHEL icon
246
CALL
Shell
SHEL
$244B
$564K 0.01%
9,800
-500
-5% -$29.4K
MET icon
247
PUT
MetLife
MET
$62.4B
$556K 0.01%
+9,600
New +$648K
MSTR icon
248
CALL
Strategy Inc
MSTR
$34.1B
$555K 0.01%
19,000
-14,000
-42% -$342K
GLD icon
249
CALL
SPDR Gold Trust
GLD
$131B
$550K 0.01%
3,000
-1,300
-30% -$229K
IEF icon
250
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
$547K 0.01%
5,520
+1,266
+30% +$124K

Similar funds

XR Securities's Q1 2023 Portfolio in Review

As of Q1 2023, XR Securities held 598 positions worth $3.83B, up 274% from $1.02B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

XR Securities deployed $2.58B of net new capital in Q1 2023, opening 97 new positions and adding to 148 existing holdings. Its largest new stake was Pinduoduo: 22,831 shares worth $1.73M.

By sector, the portfolio is most concentrated in Healthcare at 0.25% of assets, down from 1% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Union Pacific, an estimated $10.4M trimmed.

  • XR Securities's largest Q1 2023 buy was Pinduoduo: 22,831 shares worth $1.73M.
  • XR Securities added most to ProShares UltraPro Short QQQ in Q1 2023, an estimated $8.45M increase.
  • XR Securities's biggest Q1 2023 reduction was Union Pacific, cutting an estimated $10.4M.
  • XR Securities fully exited Invesco QQQ Trust in Q1 2023, selling an estimated $9.47M.
  • XR Securities's ten largest holdings make up 82% of its $3.83B portfolio in Q1 2023.
  • XR Securities opened 97 new positions and closed 190 in Q1 2023.
  • XR Securities's portfolio value rose 274% quarter-over-quarter to $3.83B.

Based on XR Securities's 13F filing for Q1 2023, filed 2 May 2023.